Drugs / GamEvac-Lyo (component B)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03333538 | Nov 2017 → Nov 2018 | — | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GamEvac-Lyo (component B) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03333538 ↗ |